Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure

BACKGROUND: Progressive remodeling after myocardial infarction (MI) is a leading cause of morbidity and mortality. Recently, glucagon-like peptide (GLP)-1 was shown to have cardioprotective effects, but treatment with GLP-1 is limited by its short half-life. It is rapidly degraded by the enzyme dipe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Meimei, Silljé, Herman HW, Meissner, Maxi, van Gilst, Wiek H, de Boer, Rudolf A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198901/
https://www.ncbi.nlm.nih.gov/pubmed/21955567
http://dx.doi.org/10.1186/1475-2840-10-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198901/
https://www.ncbi.nlm.nih.gov/pubmed/21955567
http://dx.doi.org/10.1186/1475-2840-10-85

Ejemplares similares